High serum C1q-binding adiponectin levels in male patients with acute coronary syndrome

C1q/Tumor Necrosis Factor-Related Protein-9, a Novel Adipocyte-Derived Cytokine, Attenuates Adverse Remodeling in the Ischemic Mouse Heart via Protein Kinase A Activation

(2013) Y. Sun et al.   CIRCULATION

Serum C1q- binding adiponectin in maintenance hemodialysis patients

(2013) Ken Kishida et al.   BMC Nephrology

Adiponectin, driver or passenger on the road to insulin sensitivity?

(2013) Risheng Ye et al.   Molecular Metabolism

Adiponectin, diabetes and ischemic heart failure: a challenging relationship

(2012) Samuele Baldasseroni et al.   Cardiovascular Diabetology

Three-month treatment with pioglitazone reduces circulating C1q-binding adiponectin complex to total-adiponectin ratio, without changes in body mass index, in people with type 2 diabetes

(2012) Hideaki Nakatsuji et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

PAMPs and DAMPs: signal 0s that spur autophagy and immunity

(2012) Daolin Tang et al.   IMMUNOLOGICAL REVIEWS

Correlation between serum C1q-adiponectin/total adiponectin ratio and polyvascular lesions detected by vascular ultrasonography in Japanese type 2 diabetics

(2012) Ayumu Hirata et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

High serum C1q-adiponectin/total adiponectin ratio correlates with coronary artery disease in Japanese type 2 diabetics

(2012) Ayumu Hirata et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Binding of adiponectin and C1q in human serum, and clinical significance of the measurement of C1q–adiponectin / total adiponectin ratio

(2012) Hideaki Nakatsuji et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Molecular Mechanisms of Diabetes and Atherosclerosis: Role of Adiponectin

(2012) Ken Kishida et al.   Endocrine Metabolic & Immune Disorders-Drug Targets

C1q/TNF-Related Proteins, A Family of Novel Adipokines, Induce Vascular Relaxation Through the Adiponectin Receptor-1/AMPK/eNOS/Nitric Oxide Signaling Pathway

(2011) Qijun Zheng et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Three-month treatment with pioglitazone reduces circulating levels of thiobarbituric acid-reacting substances, a marker of reactive oxidative stress, without change in body mass index, in Japanese patients with type 2 diabetes

(2010) Hideaki Nakatsuji et al.   ATHEROSCLEROSIS

Adiponectin binds C1q and activates the classical pathway of complement

(2008) Philip W. Peake et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Directing an Appropriate Immune Response: The Role of Defense Collagens and other Soluble Pattern Recognition Molecules

(2008) D. Fraser et al.   CURRENT DRUG TARGETS

Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study

(2008) R. Schnabel et al.   EUROPEAN HEART JOURNAL

Clinical Significance of High-Molecular Weight Form of Adiponectin in Male Patients With Coronary Artery Disease

(2007) Noriyuki Komura et al.   CIRCULATION JOURNAL

Decreased circulating protective adiponectin level is associated with angiographic coronary disease progression in patients with angina pectoris

(2007) Kae-Woei Liang et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY